Medicare Enrolled
Dr. Michael Danko, M.D.
Anesthesiology · Loveland, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Danko from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Danko?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Danko
Dr. Michael Danko is an anesthesiology specialist in Loveland, OH, with 18 years of NPI registration. Based on federal Medicare data, Dr. Danko performed 5,007 Medicare services across 1,987 unique beneficiaries.
Between the years covered by Open Payments, Dr. Danko received a total of $434,760 from 61 pharmaceutical and/or device companies across 1579 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Danko is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 1% volume in OH
$434,760 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,007
Medicare services
Top 1% in OH for anesthesiology
1,987
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~278 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,955 | $0 | $4 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
681 | $59 | $130 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
674 | $91 | $197 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
547 | $61 | $223 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
167 | $41 | $223 |
| Spinal drug pump reprogramming and refill A physician electronically adjusts the settings of a spinal drug infusion pump and refills its medication reservoir. |
156 | $63 | $431 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
97 | $240 | $522 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
83 | $153 | $401 |
| Electronic analysis of spinal drug pump An electronic evaluation of a spinal canal drug infusion pump to check its function and settings. |
65 | $25 | $85 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
65 | $121 | $342 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
60 | $112 | $350 |
| Electronic analysis and reprogramming of spinal drug pump This procedure involves electronically analyzing and reprogramming a spinal canal drug infusion pump. It does not include the surgical insertion or removal of the device. |
56 | $34 | $105 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
47 | $183 | $855 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
39 | $328 | $942 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
38 | $189 | $2,284 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
37 | $205 | $845 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
37 | $183 | $555 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
36 | $100 | $1,239 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
32 | $76 | $255 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
30 | $144 | $833 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
20 | $176 | $844 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
20 | $195 | $457 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
18 | $194 | $1,978 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
18 | $102 | $1,050 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
17 | $45 | $222 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $87 | $265 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$434,760
Total received (2018-2024)
Avg $62,109/year across 7 years
Top 0% in OH for anesthesiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
1,579
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$379,437 (87.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$32,517 (7.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$22,806 (5.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$57,912
2023
$54,832
2022
$59,723
2021
$63,418
2020
$51,436
2019
$82,274
2018
$65,165
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$52,142
Boston Scientific Corporation
$2,132
Abbott Laboratories
$1,502
Vertos Medical, Inc.
$550
Stryker Corporation
$297
Saluda Medical Americas, Inc.
$268
Nevro Corp.
$228
Nalu Medical, Inc.
$151
PAINTEQ LLC
$142
ABBVIE INC.
$101
Collegium Pharmaceutical, Inc.
$94
TerSera Therapeutics LLC
$75
Spinal Simplicity, LLC
$66
Axonics, Inc.
$49
IBSA Pharma Inc.
$34
PFIZER INC.
$33
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
Averitas Pharma Inc.
$16
Forte Bio-Pharma LLC
$13
Top 3 companies account for 96.3% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$189,796
Medtronic USA, Inc.
$181,820
Boston Scientific Corporation
$17,066
Abbott Laboratories
$14,404
Aurora Spine, Inc.
$14,188
Saluda Medical Americas, Inc.
$2,915
Vertos Medical, Inc.
$1,993
Vertiflex, Inc.
$1,941
MML US, Inc.
$1,923
Flowonix Medical Incorporated
$1,392
Nevro Corp.
$1,216
SurGenTec
$646
Relievant Medsystems, Inc.
$576
BOSTON SCIENTIFIC CORPORATION
$484
Stimwave Technologies Incorporated
$374
Collegium Pharmaceutical, Inc.
$364
Stryker Corporation
$297
Axonics, Inc.
$293
ABBVIE INC.
$290
Curonix LLC
$253
TerSera Therapeutics LLC
$245
Nalu Medical, Inc.
$225
Novartis Pharmaceuticals Corporation
$194
Daiichi Sankyo Inc.
$194
Jazz Pharmaceuticals Inc.
$194
AbbVie Inc.
$187
PAINTEQ LLC
$161
Amgen Inc.
$113
Spinal Simplicity, LLC
$104
PFIZER INC.
$89
GRT US Holding, Inc.
$87
Averitas Pharma Inc.
$76
Kaleo, Inc.
$51
SI-BONE, Inc.
$45
Biohaven Pharmaceuticals, Inc.
$39
IBSA Pharma Inc.
$34
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$34
BioDelivery Sciences International, Inc.
$31
Zyla Life Sciences, Inc.
$30
Hikma Pharmaceuticals USA
$29
AstraZeneca Pharmaceuticals LP
$28
Purdue Pharma L.P.
$25
ARBOR PHARMACEUTICALS, INC.
$25
Scilex Pharmaceuticals Inc.
$24
Flexion Therapeutics, Inc.
$24
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$23
Amneal Pharmaceuticals LLC
$22
SI-BONE, INC.
$22
Zyla Life Sciences
$17
US WorldMeds, LLC
$17
Bioventus LLC
$17
FIDIA PHARMA USA INC.
$14
Stratus Medical, LLC
$14
Teva Pharmaceuticals USA, Inc.
$14
Forte Bio-Pharma LLC
$13
Pernix Therapeutics Holdings, Inc.
$13
Orthogenrx Inc.
$12
Shionogi Inc
$12
Allergan Inc.
$11
Takeda Pharmaceuticals U.S.A., Inc.
$11
SPR Therapeutics, Inc
$10
Top 3 companies account for 89.4% of all-time payments
Associated products mentioned in payments ›
3D GraftRasp System · ACCURIAN · ACTIVOS 10 BONE CEMENT · ADAPTIVESTIM · AIMOVIG · AJOVY · ASCENDA · Accurian · Aimovig · Axium INS DRG IPG · Axonics · BELBUCA · BOTOX · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · DRG leads · Durolane · ETERNA · Evoke · Evoke SCS · Evzio · FUSION · GENERAL PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GenVisc 850 · General - Pain Management · HA MINUTEMAN G3-R · HYALGAN · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · INTERSTIM · IONICRF · Inflate FX · Intracept · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · Kloxxado · LIORESAL · LYRICA · LYVISPAH · Lucemyra/Lofexidine · MILD DEVICE KIT · MOVANTIK · MYSTIM · Morphabond ER · Movantik · N'VISION · NA · NALOCET · NURTEC ODT · Nalu Neurostimulation System · Nimbus · OMNICURVE · OSTEOCOOL RF ABLATION · Omnia · PAINTEQ · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Prometra II · QULIPTA · QUTENZA · Qutenza · RELISTOR · RELISTOR ORAL · RESTORE · ReActiv8 · SCS IPGs · SPECIFY SURESCAN MRI 5-6-5 · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SUPERION · SYMPROIC · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · Spectra WaveWriter · StimQ Peripheral Nerve StimulatorSystem · StimQ Receiver Stimulator Kit Channel A US w Receiver · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Superion · Superion ISS · Superion Indirect Decompression System · Symproic · TARGETSTIM · Tirosint · Trintellix · UBRELVY · VANTA ADAPTIVESTIM · VECTRIS · Vanta · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZIP · ZOHYDRO ER · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in anesthesiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for anesthesiology in OH.
Geographic Context
Anesthesiologists within 10 mi
384
Per 100K population
183.0
County median income
$83,178
Nearest hospital
BETHESDA NORTH
5.7 mi
5.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Danko is a clinical cardiology specialist, with above-average Medicare volume (top 1% in OH), with speaking/promotional industry engagement in the top 0% of OH peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Danko experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Danko performed 1,955 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Danko receive payments from pharmaceutical companies?
Yes. Dr. Danko received a total of $434,760 from 61 companies across 1,579 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Danko's costs compare to other anesthesiologists in Loveland?
Dr. Danko's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Danko) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Anesthesiologists in Loveland
Browse anesthesiologists in Loveland ranked by procedure volume and transparency data.
Highest volume
Top Anesthesiologists in OH
Anesthesiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Anesthesiologists in OH
Which OH anesthesiologists receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology